Napo Pharmaceuticals, Inc.

Napo Pharmaceuticals, Inc. is a privately-held specialty pharmaceutical company based in South San Francisco, California. Founded in November 2001, Napo is developing a late-stage drug candidate, crofelemer, for gastrointestinal indications including chronic diarrhea in persons living with HIV/AIDS. Additionally, Napo has entered into a licensing agreement for the worldwide development and commercialization of crofelemer for Irritable Bowel Syndrome.Napo is working with international pharmaceutical companies to pursue the simultaneous global development of crofelemer to create proprietary products in the developing world while maintaining commercial rights in the developed world.

Contact Details: 1170 Veterans Boulevard, Suite 244 South San Francisco California 94080 United States of America Tel: 650.616.1903 Fax: 650.873.8367 Email: cthompson@napopharma.com WWW: www.napopharma.com/

Loading...

Press Releases on Napo Pharmaceuticals, Inc.:
Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008	8th August, 2008	Insmed Inc.	RICHMOND, Va., Aug. 8 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, today reported results for the second quarter and six-months

BioNews Results for Napo Pharmaceuticals, Inc.:
Napo Acquires Rights to Additional CFTR Technology	Freshnews.com:  Oct 26 2009 11:45AM Matching: napo pharmaceuticals inc
Additional CFTR inhibitor technology licensed to Napo Pharmaceuticals	News-Medical.Net:  Oct 26 2009 10:58AM Matching: napo pharmaceuticals inc
Napo Acquires Rights to Additional CFTR Technology	Genetic Engineering News:  Oct 26 2009 11:25AM Matching: napo pharmaceuticals inc
Napo Acquires Rights to Additional CFTR Technology	Pharmacy Choice:  Oct 26 2009 9:48PM Matching: napo pharmaceuticals inc
Napo Acquires Rights to Additional CFTR Technology	Pharma Live:  Oct 26 2009 7:43PM Matching: napo pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Napo Pharmaceuticals, Inc. news.

Napo Pharmaceuticals, Inc. Patents:
US Patent No.	Title
7556831	Method for treatment of constipation-predominant irritable bowel syndrome
7341744	Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer
7323195	Enteric formulations of proanthocyanidin polymer antidiarrheal compositions

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 492 times since April 2007, the link to the organisation's website has been followed 72 times

Recent Search Terms used to find this page: napo pharmaceuticals | napo pharmaceuticals | nehpo pharmaceuticals | napo pharmaceuticals | napo pharmaceuticals | Napo pharmaceuticals 2009 | napo pharmaceuticals | napo pharmaceuticals | napo nos hospitais | .

Search for more companies in South San Francisco

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Napo Pharmaceuticals, Inc.